CS logo
small CS logo
Cardiovascular Consultants of Maine, PA

Scarborough, Maine, United States
Cardiologist in Scarborough, Maine
96 Campus Dr, Scarborough, ME 04074

About Cardiovascular Consultants of Maine, PA


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Gilead Sciences
2
American Regent, Inc.
1
Bayer
1
Cardiovascular Clinical Studies
1
Cogentus Pharmaceuticals
1
Hartford Hospital
1
Midwest Heart Foundation
1
Total Rows: 7

Clinical Trials at Cardiovascular Consultants of Maine, PA


During the past decade, Cardiovascular Consultants of Maine, PA conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100001100000000Started TrialsCompleted Trails201720182019202000.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Both Exercise and Adenosine Stress Testing
2005-06-01
Terminated
200
Drug Compliance and Quality of Life in Patients With Heart Failure Dosed With Either Once-daily or Twice-daily Coreg
2005-10-01
2006-07-01
Completed
400
The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN?
2004-06-01
2010-12-01
Completed
824
DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension
2006-06-01
2009-01-01
Completed
352
DORADO-EX: Long-Term Safety Extension Study to the Phase 3 DORADO Study (Protocol DAR-311) of Darusentan in Resistant Hypertension
2006-09-01
2010-04-01
Terminated
282
Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
2007-12-01
2009-11-01
Terminated
5,000
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
2017-03-15
2023-06-01
Active, not recruiting
3,068
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%
2020-09-14
2024-09-13
Active, not recruiting
6,016

Rows per page:

1–8 of 8

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Cardiovascular Consultants of Maine, PA" #1 sponsor was "Gilead Sciences" with 2 trials, followed by "American Regent, Inc." with 1 trials sponsored, "Bayer" with 1 trials sponsored, "Cardiovascular Clinical Studies" with 1 trials sponsored and "Cogentus Pharmaceuticals" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiovascular Consultants of Maine, PA" #1 collaborator was "GE Healthcare" with 2 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGilead Sciences: 2Gilead Sciences: 2American Regent, Inc.: 1American Regent, Inc.: 1Bayer: 1Bayer: 1Cardiovascular ClinicalStudies: 1Cardiovascular ClinicalStudies: 1Cogentus Pharmaceuticals: 1Cogentus Pharmaceuticals: 1Hartford Hospital: 1Hartford Hospital: 1Midwest Heart Foundation: 1Midwest Heart Foundation: 1

Created with Highcharts 11.1.0Top CollaboratorsGE Healthcare: 2GE Healthcare: 2Astellas Pharma US, Inc.: 1Astellas Pharma US, Inc.: 1Duke Clinical ResearchInstitute: 1Duke Clinical ResearchInstitute: 1GlaxoSmithKline: 1GlaxoSmithKline: 1

Clinical Trials Conditions at Cardiovascular Consultants of Maine, PA


According to Clinical.Site data, the most researched conditions in "Cardiovascular Consultants of Maine, PA" are "Coronary Artery Disease" (3 trials), "Heart Failure" (2 trials), "Hypertension" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Cardiovascular Consultants of Maine, PA" in a lesser frequency.

Clinical Trials Intervention Types at Cardiovascular Consultants of Maine, PA


Most popular intervention types in "Cardiovascular Consultants of Maine, PA" are "Drug" (6 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Darusentan" (2 trials), "Placebo" (2 trials), "Adenosine SPECT myocardial perfusion imaging" (1 trials), "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials) and "Combined adenosine / exercise SPECT myocardial perfusion imaging" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Cardiovascular Consultants of Maine, PA


The vast majority of trials in "Cardiovascular Consultants of Maine, PA" are 6 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Cardiovascular Consultants of Maine, PA


Currently, there are NaN active trials in "Cardiovascular Consultants of Maine, PA". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Cardiovascular Consultants of Maine, PA, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Cardiovascular Consultants of Maine, PA, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 6Phase 3: 6Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 3Completed: 3Terminated: 3Terminated: 3Active, not recruiting: 2Active, not recruiting: 2